A plethora of studies has found close associations among AD, cognitive impairment, the tau/Aβ ratio, APOE4 positive status, white matter hyperintensities, and atrophy in specific brain regions, and these may serve as potential diagnostic biomarkers of AD in the future (22, 35–40). The gene discussed is MAPT; the disease is Cognitive impairment.